nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Thiotepa—hematologic cancer	0.0572	0.0959	CbGbCtD
Perhexiline—CYP2B6—Ifosfamide—hematologic cancer	0.0325	0.0544	CbGbCtD
Perhexiline—CYP2D6—Lomustine—hematologic cancer	0.031	0.052	CbGbCtD
Perhexiline—CYP2B6—Nilotinib—hematologic cancer	0.0282	0.0473	CbGbCtD
Perhexiline—CYP2D6—Idarubicin—hematologic cancer	0.0277	0.0463	CbGbCtD
Perhexiline—CYP2D6—Hydroxyurea—hematologic cancer	0.0235	0.0394	CbGbCtD
Perhexiline—CYP3A4—Bexarotene—hematologic cancer	0.0212	0.0356	CbGbCtD
Perhexiline—CYP2D6—Bortezomib—hematologic cancer	0.0205	0.0343	CbGbCtD
Perhexiline—CYP3A4—Busulfan—hematologic cancer	0.0197	0.0331	CbGbCtD
Perhexiline—CYP3A4—Lomustine—hematologic cancer	0.0197	0.0331	CbGbCtD
Perhexiline—CYP2B6—Irinotecan—hematologic cancer	0.0194	0.0325	CbGbCtD
Perhexiline—CYP3A4—Thiotepa—hematologic cancer	0.0176	0.0295	CbGbCtD
Perhexiline—CYP2B6—Cisplatin—hematologic cancer	0.0158	0.0265	CbGbCtD
Perhexiline—CYP2D6—Imatinib—hematologic cancer	0.015	0.0251	CbGbCtD
Perhexiline—CYP3A4—Methoxsalen—hematologic cancer	0.0137	0.0229	CbGbCtD
Perhexiline—CYP2D6—Nilotinib—hematologic cancer	0.0136	0.0228	CbGbCtD
Perhexiline—CYP2D6—Vinorelbine—hematologic cancer	0.0135	0.0226	CbGbCtD
Perhexiline—CYP3A4—Bortezomib—hematologic cancer	0.013	0.0218	CbGbCtD
Perhexiline—CYP2B6—Dexamethasone—hematologic cancer	0.0128	0.0214	CbGbCtD
Perhexiline—CYP3A4—Daunorubicin—hematologic cancer	0.0124	0.0209	CbGbCtD
Perhexiline—CYP3A4—Cytarabine—hematologic cancer	0.011	0.0184	CbGbCtD
Perhexiline—CYP3A4—Teniposide—hematologic cancer	0.0108	0.0181	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—hematologic cancer	0.0106	0.0177	CbGbCtD
Perhexiline—CYP3A4—Ifosfamide—hematologic cancer	0.00998	0.0167	CbGbCtD
Perhexiline—CYP3A4—Imatinib—hematologic cancer	0.00953	0.016	CbGbCtD
Perhexiline—CYP3A4—Ruxolitinib—hematologic cancer	0.00897	0.015	CbGbCtD
Perhexiline—CYP3A4—Nilotinib—hematologic cancer	0.00866	0.0145	CbGbCtD
Perhexiline—CYP3A4—Vinorelbine—hematologic cancer	0.00859	0.0144	CbGbCtD
Perhexiline—CYP2D6—Vinblastine—hematologic cancer	0.00832	0.0139	CbGbCtD
Perhexiline—CYP3A4—Triamcinolone—hematologic cancer	0.00785	0.0132	CbGbCtD
Perhexiline—CYP3A4—Dasatinib—hematologic cancer	0.00765	0.0128	CbGbCtD
Perhexiline—CYP3A4—Mitoxantrone—hematologic cancer	0.00756	0.0127	CbGbCtD
Perhexiline—CYP3A4—Betamethasone—hematologic cancer	0.00674	0.0113	CbGbCtD
Perhexiline—CYP3A4—Prednisolone—hematologic cancer	0.00665	0.0111	CbGbCtD
Perhexiline—CYP3A4—Prednisone—hematologic cancer	0.00628	0.0105	CbGbCtD
Perhexiline—CYP2D6—Dexamethasone—hematologic cancer	0.00616	0.0103	CbGbCtD
Perhexiline—CYP3A4—Irinotecan—hematologic cancer	0.00595	0.00998	CbGbCtD
Perhexiline—CPT1A—hematopoietic system—hematologic cancer	0.00588	0.101	CbGeAlD
Perhexiline—CPT2—hematopoietic system—hematologic cancer	0.00558	0.0959	CbGeAlD
Perhexiline—CYP3A4—Vinblastine—hematologic cancer	0.00529	0.00887	CbGbCtD
Perhexiline—CYP3A4—Vincristine—hematologic cancer	0.0052	0.00872	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—hematologic cancer	0.00511	0.00857	CbGbCtD
Perhexiline—CYP3A4—Etoposide—hematologic cancer	0.00477	0.00799	CbGbCtD
Perhexiline—CPT1A—gonad—hematologic cancer	0.00447	0.0768	CbGeAlD
Perhexiline—CPT2—gonad—hematologic cancer	0.00424	0.0729	CbGeAlD
Perhexiline—CYP3A4—Dexamethasone—hematologic cancer	0.00392	0.00657	CbGbCtD
Perhexiline—CPT1A—blood—hematologic cancer	0.0039	0.0669	CbGeAlD
Perhexiline—CPT2—blood—hematologic cancer	0.0037	0.0635	CbGeAlD
Perhexiline—CPT2—bone marrow—hematologic cancer	0.00358	0.0615	CbGeAlD
Perhexiline—CPT1A—lung—hematologic cancer	0.00342	0.0587	CbGeAlD
Perhexiline—CYP3A4—Doxorubicin—hematologic cancer	0.00325	0.00545	CbGbCtD
Perhexiline—CPT2—lung—hematologic cancer	0.00324	0.0557	CbGeAlD
Perhexiline—CPT1A—testis—hematologic cancer	0.00322	0.0554	CbGeAlD
Perhexiline—CPT2—testis—hematologic cancer	0.00306	0.0525	CbGeAlD
Perhexiline—CPT1A—lymph node—hematologic cancer	0.00234	0.0401	CbGeAlD
Perhexiline—CPT2—lymph node—hematologic cancer	0.00222	0.0381	CbGeAlD
Perhexiline—CYP2B6—hematopoietic system—hematologic cancer	0.00145	0.025	CbGeAlD
Perhexiline—CYP2B6—gonad—hematologic cancer	0.0011	0.019	CbGeAlD
Perhexiline—CYP3A4—hematopoietic system—hematologic cancer	0.0011	0.0188	CbGeAlD
Perhexiline—CYP2D6—hematopoietic system—hematologic cancer	0.00108	0.0185	CbGeAlD
Perhexiline—CYP2B6—blood—hematologic cancer	0.000962	0.0165	CbGeAlD
Perhexiline—CYP2B6—lung—hematologic cancer	0.000844	0.0145	CbGeAlD
Perhexiline—CYP2B6—testis—hematologic cancer	0.000796	0.0137	CbGeAlD
Perhexiline—CYP3A4—blood—hematologic cancer	0.000727	0.0125	CbGeAlD
Perhexiline—CYP2D6—blood—hematologic cancer	0.000715	0.0123	CbGeAlD
Perhexiline—CYP2D6—testis—hematologic cancer	0.000591	0.0102	CbGeAlD
Perhexiline—Abdominal pain—Mitoxantrone—hematologic cancer	0.000107	0.000452	CcSEcCtD
Perhexiline—Abdominal pain—Irinotecan—hematologic cancer	0.000107	0.000452	CcSEcCtD
Perhexiline—Nausea—Hydroxyurea—hematologic cancer	0.000107	0.000452	CcSEcCtD
Perhexiline—Vomiting—Bortezomib—hematologic cancer	0.000107	0.000452	CcSEcCtD
Perhexiline—Decreased appetite—Cisplatin—hematologic cancer	0.000107	0.000452	CcSEcCtD
Perhexiline—Vomiting—Bleomycin—hematologic cancer	0.000106	0.000448	CcSEcCtD
Perhexiline—Rash—Bortezomib—hematologic cancer	0.000106	0.000448	CcSEcCtD
Perhexiline—Dermatitis—Bortezomib—hematologic cancer	0.000106	0.000448	CcSEcCtD
Perhexiline—Flushing—Prednisone—hematologic cancer	0.000105	0.000446	CcSEcCtD
Perhexiline—Headache—Bortezomib—hematologic cancer	0.000105	0.000445	CcSEcCtD
Perhexiline—Rash—Bleomycin—hematologic cancer	0.000105	0.000445	CcSEcCtD
Perhexiline—Dermatitis—Bleomycin—hematologic cancer	0.000105	0.000444	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—hematologic cancer	0.000105	0.000443	CcSEcCtD
Perhexiline—Asthenia—Carmustine—hematologic cancer	0.000104	0.000442	CcSEcCtD
Perhexiline—Vomiting—Vinorelbine—hematologic cancer	0.000104	0.000441	CcSEcCtD
Perhexiline—Dizziness—Thiotepa—hematologic cancer	0.000104	0.000438	CcSEcCtD
Perhexiline—Asthenia—Alitretinoin—hematologic cancer	0.000103	0.000438	CcSEcCtD
Perhexiline—Rash—Vinorelbine—hematologic cancer	0.000103	0.000438	CcSEcCtD
Perhexiline—Dermatitis—Vinorelbine—hematologic cancer	0.000103	0.000437	CcSEcCtD
Perhexiline—Headache—Vinorelbine—hematologic cancer	0.000103	0.000435	CcSEcCtD
Perhexiline—Asthenia—Ifosfamide—hematologic cancer	0.000102	0.000432	CcSEcCtD
Perhexiline—Syncope—Dexamethasone—hematologic cancer	0.000102	0.000431	CcSEcCtD
Perhexiline—Syncope—Betamethasone—hematologic cancer	0.000102	0.000431	CcSEcCtD
Perhexiline—Sweating—Methotrexate—hematologic cancer	0.000101	0.000429	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—hematologic cancer	0.000101	0.000427	CcSEcCtD
Perhexiline—Shock—Triamcinolone—hematologic cancer	0.0001	0.000425	CcSEcCtD
Perhexiline—Insomnia—Prednisolone—hematologic cancer	0.0001	0.000425	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—hematologic cancer	0.0001	0.000425	CcSEcCtD
Perhexiline—Dizziness—Thalidomide—hematologic cancer	0.0001	0.000424	CcSEcCtD
Perhexiline—Nausea—Bortezomib—hematologic cancer	9.98e-05	0.000422	CcSEcCtD
Perhexiline—Loss of consciousness—Dexamethasone—hematologic cancer	9.97e-05	0.000422	CcSEcCtD
Perhexiline—Loss of consciousness—Betamethasone—hematologic cancer	9.97e-05	0.000422	CcSEcCtD
Perhexiline—Asthenia—Vincristine—hematologic cancer	9.96e-05	0.000422	CcSEcCtD
Perhexiline—Paraesthesia—Prednisolone—hematologic cancer	9.96e-05	0.000422	CcSEcCtD
Perhexiline—Vomiting—Thiotepa—hematologic cancer	9.96e-05	0.000421	CcSEcCtD
Perhexiline—Nausea—Bleomycin—hematologic cancer	9.9e-05	0.000419	CcSEcCtD
Perhexiline—Rash—Thiotepa—hematologic cancer	9.87e-05	0.000418	CcSEcCtD
Perhexiline—Dermatitis—Thiotepa—hematologic cancer	9.87e-05	0.000418	CcSEcCtD
Perhexiline—Hyperhidrosis—Triamcinolone—hematologic cancer	9.86e-05	0.000417	CcSEcCtD
Perhexiline—Convulsion—Betamethasone—hematologic cancer	9.83e-05	0.000416	CcSEcCtD
Perhexiline—Convulsion—Dexamethasone—hematologic cancer	9.83e-05	0.000416	CcSEcCtD
Perhexiline—Headache—Thiotepa—hematologic cancer	9.81e-05	0.000415	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—hematologic cancer	9.78e-05	0.000414	CcSEcCtD
Perhexiline—Nausea—Vinorelbine—hematologic cancer	9.74e-05	0.000412	CcSEcCtD
Perhexiline—Asthenia—Mitoxantrone—hematologic cancer	9.7e-05	0.000411	CcSEcCtD
Perhexiline—Asthenia—Irinotecan—hematologic cancer	9.7e-05	0.000411	CcSEcCtD
Perhexiline—Fatigue—Etoposide—hematologic cancer	9.7e-05	0.00041	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—hematologic cancer	9.69e-05	0.00041	CcSEcCtD
Perhexiline—Vomiting—Thalidomide—hematologic cancer	9.63e-05	0.000408	CcSEcCtD
Perhexiline—Dizziness—Carmustine—hematologic cancer	9.62e-05	0.000407	CcSEcCtD
Perhexiline—Rash—Thalidomide—hematologic cancer	9.55e-05	0.000404	CcSEcCtD
Perhexiline—Dermatitis—Thalidomide—hematologic cancer	9.54e-05	0.000404	CcSEcCtD
Perhexiline—Dizziness—Alitretinoin—hematologic cancer	9.53e-05	0.000403	CcSEcCtD
Perhexiline—Headache—Thalidomide—hematologic cancer	9.49e-05	0.000402	CcSEcCtD
Perhexiline—Hepatitis—Methotrexate—hematologic cancer	9.48e-05	0.000401	CcSEcCtD
Perhexiline—Sweating—Epirubicin—hematologic cancer	9.48e-05	0.000401	CcSEcCtD
Perhexiline—Asthenia—Gemcitabine—hematologic cancer	9.45e-05	0.0004	CcSEcCtD
Perhexiline—Dizziness—Ifosfamide—hematologic cancer	9.42e-05	0.000399	CcSEcCtD
Perhexiline—Nausea—Thiotepa—hematologic cancer	9.3e-05	0.000394	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—hematologic cancer	9.28e-05	0.000393	CcSEcCtD
Perhexiline—Vomiting—Carmustine—hematologic cancer	9.25e-05	0.000391	CcSEcCtD
Perhexiline—Insomnia—Triamcinolone—hematologic cancer	9.23e-05	0.000391	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—hematologic cancer	9.2e-05	0.000389	CcSEcCtD
Perhexiline—Dizziness—Vincristine—hematologic cancer	9.18e-05	0.000389	CcSEcCtD
Perhexiline—Rash—Carmustine—hematologic cancer	9.17e-05	0.000388	CcSEcCtD
Perhexiline—Dermatitis—Carmustine—hematologic cancer	9.16e-05	0.000388	CcSEcCtD
Perhexiline—Vomiting—Alitretinoin—hematologic cancer	9.16e-05	0.000388	CcSEcCtD
Perhexiline—Paraesthesia—Triamcinolone—hematologic cancer	9.16e-05	0.000388	CcSEcCtD
Perhexiline—Headache—Carmustine—hematologic cancer	9.11e-05	0.000386	CcSEcCtD
Perhexiline—Shock—Dexamethasone—hematologic cancer	9.11e-05	0.000385	CcSEcCtD
Perhexiline—Shock—Betamethasone—hematologic cancer	9.11e-05	0.000385	CcSEcCtD
Perhexiline—Rash—Alitretinoin—hematologic cancer	9.09e-05	0.000385	CcSEcCtD
Perhexiline—Dermatitis—Alitretinoin—hematologic cancer	9.08e-05	0.000384	CcSEcCtD
Perhexiline—Vomiting—Ifosfamide—hematologic cancer	9.06e-05	0.000383	CcSEcCtD
Perhexiline—Headache—Alitretinoin—hematologic cancer	9.03e-05	0.000382	CcSEcCtD
Perhexiline—Nausea—Thalidomide—hematologic cancer	9e-05	0.000381	CcSEcCtD
Perhexiline—Rash—Ifosfamide—hematologic cancer	8.98e-05	0.00038	CcSEcCtD
Perhexiline—Dermatitis—Ifosfamide—hematologic cancer	8.97e-05	0.00038	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—hematologic cancer	8.97e-05	0.00038	CcSEcCtD
Perhexiline—Hyperhidrosis—Dexamethasone—hematologic cancer	8.95e-05	0.000379	CcSEcCtD
Perhexiline—Hyperhidrosis—Betamethasone—hematologic cancer	8.95e-05	0.000379	CcSEcCtD
Perhexiline—Dizziness—Irinotecan—hematologic cancer	8.94e-05	0.000378	CcSEcCtD
Perhexiline—Urticaria—Etoposide—hematologic cancer	8.94e-05	0.000378	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—hematologic cancer	8.89e-05	0.000376	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—hematologic cancer	8.88e-05	0.000376	CcSEcCtD
Perhexiline—Syncope—Prednisone—hematologic cancer	8.86e-05	0.000375	CcSEcCtD
Perhexiline—Vomiting—Vincristine—hematologic cancer	8.83e-05	0.000374	CcSEcCtD
Perhexiline—Anorexia—Betamethasone—hematologic cancer	8.82e-05	0.000373	CcSEcCtD
Perhexiline—Anorexia—Dexamethasone—hematologic cancer	8.82e-05	0.000373	CcSEcCtD
Perhexiline—Urticaria—Prednisolone—hematologic cancer	8.81e-05	0.000373	CcSEcCtD
Perhexiline—Asthenia—Cisplatin—hematologic cancer	8.81e-05	0.000373	CcSEcCtD
Perhexiline—Fatigue—Triamcinolone—hematologic cancer	8.8e-05	0.000372	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—hematologic cancer	8.77e-05	0.000371	CcSEcCtD
Perhexiline—Rash—Vincristine—hematologic cancer	8.76e-05	0.000371	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—hematologic cancer	8.75e-05	0.00037	CcSEcCtD
Perhexiline—Headache—Vincristine—hematologic cancer	8.7e-05	0.000368	CcSEcCtD
Perhexiline—Loss of consciousness—Prednisone—hematologic cancer	8.68e-05	0.000367	CcSEcCtD
Perhexiline—Nausea—Carmustine—hematologic cancer	8.64e-05	0.000366	CcSEcCtD
Perhexiline—Vomiting—Irinotecan—hematologic cancer	8.6e-05	0.000364	CcSEcCtD
Perhexiline—Vomiting—Mitoxantrone—hematologic cancer	8.6e-05	0.000364	CcSEcCtD
Perhexiline—Nausea—Alitretinoin—hematologic cancer	8.56e-05	0.000362	CcSEcCtD
Perhexiline—Convulsion—Prednisone—hematologic cancer	8.56e-05	0.000362	CcSEcCtD
Perhexiline—Rash—Mitoxantrone—hematologic cancer	8.53e-05	0.000361	CcSEcCtD
Perhexiline—Rash—Irinotecan—hematologic cancer	8.53e-05	0.000361	CcSEcCtD
Perhexiline—Dermatitis—Irinotecan—hematologic cancer	8.52e-05	0.000361	CcSEcCtD
Perhexiline—Dermatitis—Mitoxantrone—hematologic cancer	8.52e-05	0.000361	CcSEcCtD
Perhexiline—Headache—Mitoxantrone—hematologic cancer	8.47e-05	0.000359	CcSEcCtD
Perhexiline—Headache—Irinotecan—hematologic cancer	8.47e-05	0.000359	CcSEcCtD
Perhexiline—Nausea—Ifosfamide—hematologic cancer	8.46e-05	0.000358	CcSEcCtD
Perhexiline—Vomiting—Gemcitabine—hematologic cancer	8.38e-05	0.000354	CcSEcCtD
Perhexiline—Insomnia—Dexamethasone—hematologic cancer	8.37e-05	0.000354	CcSEcCtD
Perhexiline—Insomnia—Betamethasone—hematologic cancer	8.37e-05	0.000354	CcSEcCtD
Perhexiline—Paraesthesia—Dexamethasone—hematologic cancer	8.31e-05	0.000352	CcSEcCtD
Perhexiline—Paraesthesia—Betamethasone—hematologic cancer	8.31e-05	0.000352	CcSEcCtD
Perhexiline—Rash—Gemcitabine—hematologic cancer	8.31e-05	0.000352	CcSEcCtD
Perhexiline—Dermatitis—Gemcitabine—hematologic cancer	8.3e-05	0.000351	CcSEcCtD
Perhexiline—Headache—Gemcitabine—hematologic cancer	8.25e-05	0.000349	CcSEcCtD
Perhexiline—Nausea—Vincristine—hematologic cancer	8.25e-05	0.000349	CcSEcCtD
Perhexiline—Flushing—Epirubicin—hematologic cancer	8.24e-05	0.000349	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—hematologic cancer	8.21e-05	0.000348	CcSEcCtD
Perhexiline—Urticaria—Triamcinolone—hematologic cancer	8.11e-05	0.000343	CcSEcCtD
Perhexiline—Asthenia—Etoposide—hematologic cancer	8.07e-05	0.000342	CcSEcCtD
Perhexiline—Decreased appetite—Dexamethasone—hematologic cancer	8.05e-05	0.000341	CcSEcCtD
Perhexiline—Decreased appetite—Betamethasone—hematologic cancer	8.05e-05	0.000341	CcSEcCtD
Perhexiline—Nausea—Irinotecan—hematologic cancer	8.03e-05	0.00034	CcSEcCtD
Perhexiline—Nausea—Mitoxantrone—hematologic cancer	8.03e-05	0.00034	CcSEcCtD
Perhexiline—Fatigue—Betamethasone—hematologic cancer	7.98e-05	0.000338	CcSEcCtD
Perhexiline—Fatigue—Dexamethasone—hematologic cancer	7.98e-05	0.000338	CcSEcCtD
Perhexiline—Shock—Prednisone—hematologic cancer	7.93e-05	0.000336	CcSEcCtD
Perhexiline—Nausea—Gemcitabine—hematologic cancer	7.83e-05	0.000331	CcSEcCtD
Perhexiline—Vomiting—Cisplatin—hematologic cancer	7.81e-05	0.00033	CcSEcCtD
Perhexiline—Hyperhidrosis—Prednisone—hematologic cancer	7.79e-05	0.00033	CcSEcCtD
Perhexiline—Rash—Cisplatin—hematologic cancer	7.74e-05	0.000328	CcSEcCtD
Perhexiline—Dermatitis—Cisplatin—hematologic cancer	7.74e-05	0.000327	CcSEcCtD
Perhexiline—Anorexia—Prednisone—hematologic cancer	7.69e-05	0.000325	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—hematologic cancer	7.62e-05	0.000323	CcSEcCtD
Perhexiline—Tension—Epirubicin—hematologic cancer	7.58e-05	0.000321	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.57e-05	0.00032	CcSEcCtD
Perhexiline—Gastrointestinal pain—Betamethasone—hematologic cancer	7.57e-05	0.00032	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—hematologic cancer	7.5e-05	0.000318	CcSEcCtD
Perhexiline—Dizziness—Etoposide—hematologic cancer	7.44e-05	0.000315	CcSEcCtD
Perhexiline—Urticaria—Dexamethasone—hematologic cancer	7.35e-05	0.000311	CcSEcCtD
Perhexiline—Urticaria—Betamethasone—hematologic cancer	7.35e-05	0.000311	CcSEcCtD
Perhexiline—Dizziness—Prednisolone—hematologic cancer	7.34e-05	0.000311	CcSEcCtD
Perhexiline—Asthenia—Triamcinolone—hematologic cancer	7.32e-05	0.00031	CcSEcCtD
Perhexiline—Abdominal pain—Dexamethasone—hematologic cancer	7.32e-05	0.00031	CcSEcCtD
Perhexiline—Abdominal pain—Betamethasone—hematologic cancer	7.32e-05	0.00031	CcSEcCtD
Perhexiline—Nausea—Cisplatin—hematologic cancer	7.29e-05	0.000309	CcSEcCtD
Perhexiline—Insomnia—Prednisone—hematologic cancer	7.29e-05	0.000309	CcSEcCtD
Perhexiline—Paraesthesia—Prednisone—hematologic cancer	7.24e-05	0.000306	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—hematologic cancer	7.15e-05	0.000303	CcSEcCtD
Perhexiline—Vomiting—Etoposide—hematologic cancer	7.15e-05	0.000303	CcSEcCtD
Perhexiline—Rash—Etoposide—hematologic cancer	7.09e-05	0.0003	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—hematologic cancer	7.09e-05	0.0003	CcSEcCtD
Perhexiline—Headache—Etoposide—hematologic cancer	7.05e-05	0.000298	CcSEcCtD
Perhexiline—Tension—Doxorubicin—hematologic cancer	7.02e-05	0.000297	CcSEcCtD
Perhexiline—Decreased appetite—Prednisone—hematologic cancer	7.01e-05	0.000297	CcSEcCtD
Perhexiline—Rash—Prednisolone—hematologic cancer	7e-05	0.000296	CcSEcCtD
Perhexiline—Dermatitis—Prednisolone—hematologic cancer	6.99e-05	0.000296	CcSEcCtD
Perhexiline—Fatigue—Prednisone—hematologic cancer	6.95e-05	0.000294	CcSEcCtD
Perhexiline—Headache—Prednisolone—hematologic cancer	6.95e-05	0.000294	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—hematologic cancer	6.94e-05	0.000294	CcSEcCtD
Perhexiline—Syncope—Epirubicin—hematologic cancer	6.93e-05	0.000293	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—hematologic cancer	6.79e-05	0.000287	CcSEcCtD
Perhexiline—Dizziness—Triamcinolone—hematologic cancer	6.75e-05	0.000286	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—hematologic cancer	6.69e-05	0.000283	CcSEcCtD
Perhexiline—Nausea—Etoposide—hematologic cancer	6.68e-05	0.000283	CcSEcCtD
Perhexiline—Asthenia—Betamethasone—hematologic cancer	6.64e-05	0.000281	CcSEcCtD
Perhexiline—Asthenia—Dexamethasone—hematologic cancer	6.64e-05	0.000281	CcSEcCtD
Perhexiline—Gastrointestinal pain—Prednisone—hematologic cancer	6.59e-05	0.000279	CcSEcCtD
Perhexiline—Nausea—Prednisolone—hematologic cancer	6.59e-05	0.000279	CcSEcCtD
Perhexiline—Hyperhidrosis—Methotrexate—hematologic cancer	6.51e-05	0.000276	CcSEcCtD
Perhexiline—Vomiting—Triamcinolone—hematologic cancer	6.49e-05	0.000275	CcSEcCtD
Perhexiline—Rash—Triamcinolone—hematologic cancer	6.43e-05	0.000272	CcSEcCtD
Perhexiline—Dermatitis—Triamcinolone—hematologic cancer	6.43e-05	0.000272	CcSEcCtD
Perhexiline—Anorexia—Methotrexate—hematologic cancer	6.42e-05	0.000272	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—hematologic cancer	6.41e-05	0.000271	CcSEcCtD
Perhexiline—Urticaria—Prednisone—hematologic cancer	6.41e-05	0.000271	CcSEcCtD
Perhexiline—Headache—Triamcinolone—hematologic cancer	6.39e-05	0.000271	CcSEcCtD
Perhexiline—Abdominal pain—Prednisone—hematologic cancer	6.37e-05	0.00027	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—hematologic cancer	6.28e-05	0.000266	CcSEcCtD
Perhexiline—Shock—Epirubicin—hematologic cancer	6.2e-05	0.000263	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—hematologic cancer	6.19e-05	0.000262	CcSEcCtD
Perhexiline—Dizziness—Dexamethasone—hematologic cancer	6.12e-05	0.000259	CcSEcCtD
Perhexiline—Dizziness—Betamethasone—hematologic cancer	6.12e-05	0.000259	CcSEcCtD
Perhexiline—Hyperhidrosis—Epirubicin—hematologic cancer	6.1e-05	0.000258	CcSEcCtD
Perhexiline—Insomnia—Methotrexate—hematologic cancer	6.09e-05	0.000258	CcSEcCtD
Perhexiline—Nausea—Triamcinolone—hematologic cancer	6.06e-05	0.000256	CcSEcCtD
Perhexiline—Paraesthesia—Methotrexate—hematologic cancer	6.05e-05	0.000256	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—hematologic cancer	6.01e-05	0.000254	CcSEcCtD
Perhexiline—Vomiting—Betamethasone—hematologic cancer	5.89e-05	0.000249	CcSEcCtD
Perhexiline—Vomiting—Dexamethasone—hematologic cancer	5.89e-05	0.000249	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ADCY7—hematologic cancer	5.87e-05	0.000539	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NCOA3—hematologic cancer	5.87e-05	0.000539	CbGpPWpGaD
Perhexiline—Decreased appetite—Methotrexate—hematologic cancer	5.86e-05	0.000248	CcSEcCtD
Perhexiline—Rash—Betamethasone—hematologic cancer	5.84e-05	0.000247	CcSEcCtD
Perhexiline—Rash—Dexamethasone—hematologic cancer	5.84e-05	0.000247	CcSEcCtD
Perhexiline—Dermatitis—Betamethasone—hematologic cancer	5.83e-05	0.000247	CcSEcCtD
Perhexiline—Dermatitis—Dexamethasone—hematologic cancer	5.83e-05	0.000247	CcSEcCtD
Perhexiline—CPT1A—Metabolism—NUP214—hematologic cancer	5.83e-05	0.000535	CbGpPWpGaD
Perhexiline—Fatigue—Methotrexate—hematologic cancer	5.81e-05	0.000246	CcSEcCtD
Perhexiline—Headache—Betamethasone—hematologic cancer	5.8e-05	0.000245	CcSEcCtD
Perhexiline—Headache—Dexamethasone—hematologic cancer	5.8e-05	0.000245	CcSEcCtD
Perhexiline—Asthenia—Prednisone—hematologic cancer	5.78e-05	0.000245	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.77e-05	0.00053	CbGpPWpGaD
Perhexiline—Shock—Doxorubicin—hematologic cancer	5.74e-05	0.000243	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ABCG2—hematologic cancer	5.71e-05	0.000525	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTR—hematologic cancer	5.71e-05	0.000525	CbGpPWpGaD
Perhexiline—Insomnia—Epirubicin—hematologic cancer	5.7e-05	0.000241	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—hematologic cancer	5.66e-05	0.00024	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—hematologic cancer	5.64e-05	0.000239	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ENO2—hematologic cancer	5.6e-05	0.000514	CbGpPWpGaD
Perhexiline—Anorexia—Doxorubicin—hematologic cancer	5.56e-05	0.000235	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.51e-05	0.000506	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Methotrexate—hematologic cancer	5.51e-05	0.000233	CcSEcCtD
Perhexiline—Nausea—Betamethasone—hematologic cancer	5.5e-05	0.000233	CcSEcCtD
Perhexiline—Nausea—Dexamethasone—hematologic cancer	5.5e-05	0.000233	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—MTR—hematologic cancer	5.49e-05	0.000505	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—hematologic cancer	5.49e-05	0.000504	CbGpPWpGaD
Perhexiline—Decreased appetite—Epirubicin—hematologic cancer	5.48e-05	0.000232	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—hematologic cancer	5.44e-05	0.00023	CcSEcCtD
Perhexiline—CPT2—Metabolism—GSTP1—hematologic cancer	5.43e-05	0.000499	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTT1—hematologic cancer	5.43e-05	0.000499	CbGpPWpGaD
Perhexiline—Urticaria—Methotrexate—hematologic cancer	5.35e-05	0.000227	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.35e-05	0.000491	CbGpPWpGaD
Perhexiline—Dizziness—Prednisone—hematologic cancer	5.33e-05	0.000226	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—hematologic cancer	5.33e-05	0.000225	CcSEcCtD
Perhexiline—CPT1A—Metabolism—SDC1—hematologic cancer	5.31e-05	0.000488	CbGpPWpGaD
Perhexiline—Insomnia—Doxorubicin—hematologic cancer	5.28e-05	0.000223	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.26e-05	0.000483	CbGpPWpGaD
Perhexiline—Paraesthesia—Doxorubicin—hematologic cancer	5.24e-05	0.000222	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	5.22e-05	0.00048	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—hematologic cancer	5.21e-05	0.000479	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Epirubicin—hematologic cancer	5.16e-05	0.000218	CcSEcCtD
Perhexiline—CPT2—Metabolism—ABCB1—hematologic cancer	5.14e-05	0.000472	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—hematologic cancer	5.14e-05	0.000472	CbGpPWpGaD
Perhexiline—Vomiting—Prednisone—hematologic cancer	5.13e-05	0.000217	CcSEcCtD
Perhexiline—Rash—Prednisone—hematologic cancer	5.08e-05	0.000215	CcSEcCtD
Perhexiline—Dermatitis—Prednisone—hematologic cancer	5.08e-05	0.000215	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—hematologic cancer	5.07e-05	0.000215	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.07e-05	0.000466	CbGpPWpGaD
Perhexiline—Headache—Prednisone—hematologic cancer	5.05e-05	0.000214	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—hematologic cancer	5.03e-05	0.000213	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—hematologic cancer	5.01e-05	0.000212	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.01e-05	0.00046	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NCOR1—hematologic cancer	4.99e-05	0.000459	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTM1—hematologic cancer	4.99e-05	0.000459	CbGpPWpGaD
Perhexiline—Abdominal pain—Epirubicin—hematologic cancer	4.98e-05	0.000211	CcSEcCtD
Perhexiline—Asthenia—Methotrexate—hematologic cancer	4.83e-05	0.000205	CcSEcCtD
Perhexiline—Nausea—Prednisone—hematologic cancer	4.79e-05	0.000203	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.79e-05	0.00044	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTM1—hematologic cancer	4.79e-05	0.00044	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTM1—hematologic cancer	4.72e-05	0.000434	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—hematologic cancer	4.64e-05	0.000196	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—hematologic cancer	4.61e-05	0.000195	CcSEcCtD
Perhexiline—Asthenia—Epirubicin—hematologic cancer	4.52e-05	0.000191	CcSEcCtD
Perhexiline—CPT1A—Metabolism—NQO1—hematologic cancer	4.51e-05	0.000415	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CD44—hematologic cancer	4.51e-05	0.000415	CbGpPWpGaD
Perhexiline—Dizziness—Methotrexate—hematologic cancer	4.46e-05	0.000189	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.42e-05	0.000406	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MTHFR—hematologic cancer	4.41e-05	0.000405	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.4e-05	0.000405	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	4.34e-05	0.000399	CbGpPWpGaD
Perhexiline—Vomiting—Methotrexate—hematologic cancer	4.28e-05	0.000181	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CYCS—hematologic cancer	4.27e-05	0.000392	CbGpPWpGaD
Perhexiline—Rash—Methotrexate—hematologic cancer	4.25e-05	0.00018	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—hematologic cancer	4.24e-05	0.00018	CcSEcCtD
Perhexiline—CPT1A—Metabolism—HSP90AA1—hematologic cancer	4.24e-05	0.00039	CbGpPWpGaD
Perhexiline—Headache—Methotrexate—hematologic cancer	4.22e-05	0.000179	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—hematologic cancer	4.19e-05	0.000177	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—hematologic cancer	4.17e-05	0.000176	CcSEcCtD
Perhexiline—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	4.14e-05	0.00038	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	4.08e-05	0.000375	CbGpPWpGaD
Perhexiline—Vomiting—Epirubicin—hematologic cancer	4.01e-05	0.00017	CcSEcCtD
Perhexiline—Nausea—Methotrexate—hematologic cancer	4e-05	0.000169	CcSEcCtD
Perhexiline—CYP2B6—Metabolism—PHYH—hematologic cancer	3.99e-05	0.000367	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GMPS—hematologic cancer	3.99e-05	0.000367	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FTCD—hematologic cancer	3.99e-05	0.000367	CbGpPWpGaD
Perhexiline—Rash—Epirubicin—hematologic cancer	3.98e-05	0.000168	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—hematologic cancer	3.97e-05	0.000168	CcSEcCtD
Perhexiline—Headache—Epirubicin—hematologic cancer	3.95e-05	0.000167	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.89e-05	0.000357	CbGpPWpGaD
Perhexiline—Dizziness—Doxorubicin—hematologic cancer	3.86e-05	0.000163	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.82e-05	0.000351	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—hematologic cancer	3.77e-05	0.000346	CbGpPWpGaD
Perhexiline—Nausea—Epirubicin—hematologic cancer	3.75e-05	0.000159	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—hematologic cancer	3.71e-05	0.000157	CcSEcCtD
Perhexiline—CPT2—Metabolism—PIK3CG—hematologic cancer	3.71e-05	0.00034	CbGpPWpGaD
Perhexiline—Rash—Doxorubicin—hematologic cancer	3.68e-05	0.000156	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—hematologic cancer	3.68e-05	0.000156	CcSEcCtD
Perhexiline—Headache—Doxorubicin—hematologic cancer	3.66e-05	0.000155	CcSEcCtD
Perhexiline—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.65e-05	0.000336	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SMPD3—hematologic cancer	3.65e-05	0.000335	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.64e-05	0.000335	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	3.62e-05	0.000333	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.59e-05	0.00033	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	3.57e-05	0.000328	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—hematologic cancer	3.56e-05	0.000327	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—hematologic cancer	3.47e-05	0.000147	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GSTM1—hematologic cancer	3.46e-05	0.000318	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NCOR1—hematologic cancer	3.46e-05	0.000318	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CREBBP—hematologic cancer	3.44e-05	0.000316	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.42e-05	0.000314	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	3.33e-05	0.000306	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	3.28e-05	0.000301	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CD—hematologic cancer	3.26e-05	0.000299	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALB—hematologic cancer	3.22e-05	0.000295	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ASNS—hematologic cancer	3.19e-05	0.000293	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DCK—hematologic cancer	3.19e-05	0.000293	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—B3GAT1—hematologic cancer	3.19e-05	0.000293	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3R1—hematologic cancer	3.08e-05	0.000283	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTHFR—hematologic cancer	3.06e-05	0.000281	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HDC—hematologic cancer	3.03e-05	0.000278	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CB—hematologic cancer	2.84e-05	0.000261	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FTCD—hematologic cancer	2.77e-05	0.000255	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PHYH—hematologic cancer	2.77e-05	0.000255	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GMPS—hematologic cancer	2.77e-05	0.000255	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CDA—hematologic cancer	2.77e-05	0.000254	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.69e-05	0.000248	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PC—hematologic cancer	2.66e-05	0.000245	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GBA—hematologic cancer	2.57e-05	0.000236	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC35B2—hematologic cancer	2.57e-05	0.000236	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CG—hematologic cancer	2.57e-05	0.000236	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.54e-05	0.000233	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—hematologic cancer	2.45e-05	0.000225	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CREBBP—hematologic cancer	2.38e-05	0.000219	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.37e-05	0.000217	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTAP—hematologic cancer	2.35e-05	0.000216	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—EP300—hematologic cancer	2.34e-05	0.000215	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.33e-05	0.000214	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CD—hematologic cancer	2.26e-05	0.000207	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALB—hematologic cancer	2.23e-05	0.000205	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.22e-05	0.000204	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ASNS—hematologic cancer	2.22e-05	0.000204	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DCK—hematologic cancer	2.22e-05	0.000204	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.18e-05	0.0002	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.15e-05	0.000197	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3R1—hematologic cancer	2.13e-05	0.000196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HDC—hematologic cancer	2.1e-05	0.000193	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FHL2—hematologic cancer	2.1e-05	0.000193	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AGRN—hematologic cancer	2.06e-05	0.000189	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CB—hematologic cancer	1.97e-05	0.000181	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HMMR—hematologic cancer	1.95e-05	0.000179	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—IDH2—hematologic cancer	1.95e-05	0.000179	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CDA—hematologic cancer	1.92e-05	0.000177	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PC—hematologic cancer	1.85e-05	0.00017	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ARNTL—hematologic cancer	1.83e-05	0.000168	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GMPS—hematologic cancer	1.81e-05	0.000167	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PHYH—hematologic cancer	1.81e-05	0.000167	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FTCD—hematologic cancer	1.81e-05	0.000167	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GBA—hematologic cancer	1.79e-05	0.000164	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.79e-05	0.000164	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA9—hematologic cancer	1.78e-05	0.000164	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ACP5—hematologic cancer	1.78e-05	0.000164	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOR2—hematologic cancer	1.76e-05	0.000162	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—hematologic cancer	1.73e-05	0.000159	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—hematologic cancer	1.7e-05	0.000156	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—IDH1—hematologic cancer	1.68e-05	0.000154	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.66e-05	0.000152	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCC3—hematologic cancer	1.66e-05	0.000152	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTO1—hematologic cancer	1.66e-05	0.000152	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TXN—hematologic cancer	1.66e-05	0.000152	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTAP—hematologic cancer	1.64e-05	0.00015	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—hematologic cancer	1.62e-05	0.000149	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SPHK1—hematologic cancer	1.62e-05	0.000149	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—UGT1A1—hematologic cancer	1.56e-05	0.000143	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC22A1—hematologic cancer	1.52e-05	0.000139	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CRABP1—hematologic cancer	1.52e-05	0.000139	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALOX5—hematologic cancer	1.48e-05	0.000136	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FHL2—hematologic cancer	1.46e-05	0.000134	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DCK—hematologic cancer	1.45e-05	0.000133	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.45e-05	0.000133	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ASNS—hematologic cancer	1.45e-05	0.000133	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NUP98—hematologic cancer	1.43e-05	0.000131	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AGRN—hematologic cancer	1.43e-05	0.000131	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—hematologic cancer	1.41e-05	0.00013	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ADCY7—hematologic cancer	1.39e-05	0.000128	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOA3—hematologic cancer	1.39e-05	0.000128	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NUP214—hematologic cancer	1.38e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HDC—hematologic cancer	1.37e-05	0.000126	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—IDH2—hematologic cancer	1.36e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HMMR—hematologic cancer	1.36e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTR—hematologic cancer	1.35e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCG2—hematologic cancer	1.35e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ENO2—hematologic cancer	1.33e-05	0.000122	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—hematologic cancer	1.29e-05	0.000118	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.27e-05	0.000117	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CDA—hematologic cancer	1.26e-05	0.000116	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SDC1—hematologic cancer	1.26e-05	0.000115	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACP5—hematologic cancer	1.24e-05	0.000114	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA9—hematologic cancer	1.24e-05	0.000114	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.22e-05	0.000112	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PC—hematologic cancer	1.21e-05	0.000111	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—hematologic cancer	1.2e-05	0.00011	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GBA—hematologic cancer	1.17e-05	0.000107	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.17e-05	0.000107	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—IDH1—hematologic cancer	1.17e-05	0.000107	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TXN—hematologic cancer	1.15e-05	0.000106	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.15e-05	0.000106	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.15e-05	0.000106	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.13e-05	0.000104	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.08e-05	9.95e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTAP—hematologic cancer	1.07e-05	9.82e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CD44—hematologic cancer	1.07e-05	9.81e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NQO1—hematologic cancer	1.07e-05	9.81e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.05e-05	9.68e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.05e-05	9.68e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.03e-05	9.43e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYCS—hematologic cancer	1.01e-05	9.29e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	1e-05	9.23e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NUP98—hematologic cancer	9.95e-06	9.14e-05	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—hematologic cancer	9.8e-06	9.01e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ADCY7—hematologic cancer	9.66e-06	8.87e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOA3—hematologic cancer	9.66e-06	8.87e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NUP214—hematologic cancer	9.59e-06	8.81e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FHL2—hematologic cancer	9.53e-06	8.75e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTR—hematologic cancer	9.39e-06	8.63e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCG2—hematologic cancer	9.39e-06	8.63e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AGRN—hematologic cancer	9.35e-06	8.59e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ENO2—hematologic cancer	9.21e-06	8.46e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—hematologic cancer	8.93e-06	8.21e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—hematologic cancer	8.91e-06	8.18e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—IDH2—hematologic cancer	8.86e-06	8.14e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HMMR—hematologic cancer	8.86e-06	8.14e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SDC1—hematologic cancer	8.73e-06	8.02e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—hematologic cancer	8.43e-06	7.75e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.33e-06	7.65e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOR1—hematologic cancer	8.19e-06	7.52e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—hematologic cancer	8.19e-06	7.52e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA9—hematologic cancer	8.1e-06	7.44e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACP5—hematologic cancer	8.1e-06	7.44e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOR2—hematologic cancer	8e-06	7.35e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—IDH1—hematologic cancer	7.62e-06	7e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.53e-06	6.92e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.53e-06	6.92e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TXN—hematologic cancer	7.53e-06	6.92e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NQO1—hematologic cancer	7.42e-06	6.82e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CD44—hematologic cancer	7.42e-06	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.37e-06	6.77e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—hematologic cancer	7.24e-06	6.65e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.08e-06	6.51e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYCS—hematologic cancer	7.03e-06	6.45e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	6.98e-06	6.41e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.89e-06	6.33e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.89e-06	6.33e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.71e-06	6.17e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NUP98—hematologic cancer	6.5e-06	5.97e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.31e-06	5.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.31e-06	5.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NUP214—hematologic cancer	6.27e-06	5.76e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—hematologic cancer	6.19e-06	5.69e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTR—hematologic cancer	6.14e-06	5.64e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.14e-06	5.64e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CG—hematologic cancer	6.08e-06	5.58e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ENO2—hematologic cancer	6.02e-06	5.53e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—hematologic cancer	5.86e-06	5.38e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.84e-06	5.37e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SDC1—hematologic cancer	5.71e-06	5.24e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.69e-06	5.23e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.69e-06	5.23e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CREBBP—hematologic cancer	5.64e-06	5.18e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CD—hematologic cancer	5.34e-06	4.91e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALB—hematologic cancer	5.28e-06	4.85e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3R1—hematologic cancer	5.05e-06	4.64e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.03e-06	4.62e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CD44—hematologic cancer	4.85e-06	4.46e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NQO1—hematologic cancer	4.85e-06	4.46e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CB—hematologic cancer	4.66e-06	4.28e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYCS—hematologic cancer	4.59e-06	4.22e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.56e-06	4.19e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.23e-06	3.88e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.05e-06	3.72e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—hematologic cancer	4.03e-06	3.7e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.92e-06	3.6e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—hematologic cancer	3.84e-06	3.53e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.83e-06	3.52e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.72e-06	3.42e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.72e-06	3.42e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.71e-06	3.41e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALB—hematologic cancer	3.67e-06	3.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.51e-06	3.22e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.29e-06	3.02e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.24e-06	2.97e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.84e-06	2.61e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—hematologic cancer	2.8e-06	2.57e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.76e-06	2.54e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—hematologic cancer	2.67e-06	2.45e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.56e-06	2.35e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.43e-06	2.23e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALB—hematologic cancer	2.4e-06	2.2e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—hematologic cancer	2.32e-06	2.13e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.29e-06	2.11e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.12e-06	1.94e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.97e-06	1.81e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—hematologic cancer	1.83e-06	1.68e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—hematologic cancer	1.74e-06	1.6e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—hematologic cancer	1.61e-06	1.48e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.29e-06	1.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—hematologic cancer	1.05e-06	9.68e-06	CbGpPWpGaD
